SGTX
Sigilon Therapeutics, Inc. Common Stock
SGTX
SGTX
Delisted
SGTX was delisted on the 10th of August, 2023.
52 hedge funds and large institutions have $209M invested in Sigilon Therapeutics, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding in top 10
Funds holding in top 10: →
52% less capital invested
Capital invested by funds: $438M → $209M (-$230M)
Holders
52
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$5.85M | |
| 2 | +$3.41M | |
| 3 | +$2.38M | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$1.42M |
| 5 |
BlackRock
New York
|
+$1.28M |
Top Sellers
| 1 | -$19M | |
| 2 | -$6.11M | |
| 3 | -$2.76M | |
| 4 |
Millennium Management
New York
|
-$2.33M |
| 5 |
CCM
CAAS Capital Management
New York
|
-$782K |